FEATURED COMPANIES
- Abbott
- Arkray
- B. Braun Melsungen AG
- Biocon Ltd.
- Dexcom
- Eli Lilly and Company
Insulin Pens, Syringes, Pumps And Injectors Global Market Opportunities And Strategies To 2030 from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global insulin pens, syringes, pumps and injectors market.
Reasons to Purchase
- Outperform competitors using accurate up to date demand-side dynamics information.
- Identify growth segments for investment.
- Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
- Create regional and country strategies on the basis of local data and analysis.
- Stay abreast of the latest customer and market research findings
- Benchmark performance against key competitors.
- Develop strategies based on likely future developments.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest-growing market for the insulin pens, syringes, pumps and injectors market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global insulin pens, syringes, pumps and injectors market report to 2030 report from the publisher answers all these questions and many more.
The report covers the following chapters
- Executive Summary –The executive summary section of the report gives a brief overview and summary of the report
- Report Structure – This section gives the structure of the report and the information covered in the various sections.
- Introduction -The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type.
- Market Characteristics –The market characteristics section of the report defines and explains the insulin pens, syringes, pumps and injectors market. This chapter includes different products covered in the report and basic definitions.
- Supply Chain –The supply chain section of the report defines and explains the key players in the insulin pens, syringes, pumps and injectors industry supply chain.
- Customer Information– This chapters covers recent customers’ trends/preferences in the global insulin pens, syringes, pumps and injectors market.
- Trends And Strategies – This chapter describes the major trends shaping the global insulin pens, syringes, pumps and injectors market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
- Regional And Country Analysis – This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries.
- Market Segmentation –This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments (by type of device, by end user, by type of pens, by type of injectors and pumps, and by type of pumps) in the market.
- Regional Market Size And Growth–This section contains the region’s market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
- Competitive Landscape – This section covers details on the competitive landscape of the global insulin pens, syringes, pumps and injectors market, estimated market shares and company profiles of the leading players.
- Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Background – This section describes the diabetes care devices market of which the insulin pens, syringes, pumps and injectors market is a segment. This chapter includes the nursing care market 2015-23 values, and regional analyses for the diabetes care devices market.
- Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
- Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- By Type Of Device: Pens; Injectors And Pumps; Syringes
- Insulin Pens market is further segmented into Reusable Insulin Pens, and Disposable Insulin Pens
- Insulin Pumps market is further segmented into Tubed Insulin Pumps, and Tubeless Insulin Pumps
- By Type Of End User: Homecare, Hospitals, Others
- By Type Of Expenditure: Public Healthcare Expenditure, Private Healthcare Expenditure
Companies Mentioned: Eli Lilly and Company; Medtronic plc; Becton, Dickinson and Company; Novo Nordisk A/S; Insulet Corporation
Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Germany, France, Spain, UK, Russia, and Brazil.
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast, three years further forecast, and six years further forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott
- Arkray
- B. Braun Melsungen AG
- Biocon Ltd.
- Dexcom
- Eli Lilly and Company
1. Insulin Pens, Syringes, Pumps And Injectors Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure8. Insulin Pens, Syringes, Pumps And Injectors Market Product Analysis27. Copyright and Disclaimer
6. Introduction
7. Insulin Pens, Syringes, Pumps And Injectors Market Characteristics
9. Insulin Pens, Syringes, Pumps And Injectors Market,Customer Information
10. Insulin Pens, Syringes, Pumps And Injectors Market Trends And Strategies
11. Global Insulin Pens, Syringes, Pumps And Injectors Market Size And Growth
12. Global Insulin Pens, Syringes, Pumps And Injectors Market Segmentation
13. Insulin Pens, Syringes, Pumps And Injectors Market, Regional And Country Analysis
14. Asia-Pacific Insulin Pens, Syringes, Pumps And Injectors Market
15. Western Europe Insulin Pens, Syringes, Pumps And Injectors Market
16. Eastern Europe Insulin Pens, Syringes, Pumps And Injectors Market
17. North America Insulin Pens, Syringes, Pumps And Injectors Market
18. South America Insulin Pens, Syringes, Pumps And Injectors Market
19. Middle East Insulin Pens, Syringes, Pumps And Injectors Market
20. Africa Insulin Pens, Syringes, Pumps And Injectors Market
21. Global Insulin Pens, Syringes, Pumps And Injectors Market Competitive Landscape
22. Key Mergers And Acquisitions In The Insulin Pens, Syringes, Pumps And Injectors Market
23. Market Background: Diabetes Care Devices
24. Global Insulin Pens, Syringes, Pumps And Injectors Market Opportunities And Strategies
25. Global Insulin Pens, Syringes, Pumps And Injectors Market Conclusions And Recommendations
26. Appendix
Note: Product cover images may vary from those shown
LOADING...
FEATURED COMPANIES
- Abbott
- Arkray
- B. Braun Melsungen AG
- Biocon Ltd.
- Dexcom
- Eli Lilly and Company
This report describes and evaluates the global insulin pens, syringes, pumps and injectors market. It covers two five-year periods, one three-year period and one six-year period including, 2015 to 2019, termed the historic period, and 2019 to 2023 forecast period, 2023-2025 forecast period and 2025 -2030 the forecast period.
The global insulin pens, syringes, pumps and injectors market reached a value of nearly $16,148.7 million in 2019, having grown at a compound annual growth rate (CAGR) of 7.42% since 2015, and is expected to grow at a CAGR of 8.71% to nearly $22,553.3 million by 2023. Also, the market is expected to grow to $26,335.1 million in 2025 at a CAGR of 8.06% and to $ 38,137.9 million in 2030 at a CAGR of 7.69%.
Growth in the historic period resulted from increase in diabetes prevalence, increase in R&D investments and research collaborations, and increase in disposable income. Factors that negatively affected growth in the historic period were lack of awareness, and preference for oral treatment.
Going forward, rise in diabetic population, rapid technological advances, and favorable government initiatives are expected to drive the market. Factors that could hinder the growth of the insulin pens, syringes, pumps and injectors market in the future include government regulations, and availability of alternative treatments.
The insulin pens, syringes, pumps and injectors market is segmented by type of device into pens, injectors and pumps, and syringes. The pens market was the largest segment of the insulin pens, syringes, pumps and injectors market, accounting for $7,698.1 million or 47.7% of the total market in 2019. It is also expected to be the fastest growing segment going forward at a CAGR of 9.0% during 2019-2023.
The insulin pens, syringes, pumps and injectors market is also segmented by type of end user into homecare, hospitals, and others. The homecare was the largest segment of the insulin pens, syringes, pumps and injectors market by end user, accounting for $8,951.9 million or 55.4% of the total market in 2019. It is also expected to be the fastest-growing segment going forward at a CAGR of 9.2% during 2019-2023.
The pens market is further segmented by type of pens into disposable pens, and reusable pens. The disposable pens was the largest segment of the pens market by type of pen, accounting for $4,739.1 million or 61.6% of the total market in 2019. It is also expected to be the fastest-growing segment going forward at a CAGR of 9.4% during 2019-2023.
The injectors and pumps market is further segmented by type of injectors and pumps into pumps, and injectors. The pumps was the largest segment of the injectors and pumps market by type, accounting for $3,616.8 million or 53.5% of the total market in 2019. It is also expected to be the fastest-growing segment going forward at a CAGR of 9.6% during 2019-2023.
The pumps market is further segmented by type of pumps into tubed, and tubeless. The tubed pumps was the largest segment of the pumps market by type of pump, accounting for $ 2,750.0 million or 76.0% of the total market in 2019. The tubeless pumps segment is expected to be the fastest-growing segment going forward at a CAGR of 18.5% during 2019-2023.
North America was the largest region in the insulin pens, syringes, pumps and injectors market, accounting for 47.3% of the global market in 2019. It was followed by Asia Pacific and Western Europe, and the other regions. Going forward, the fastest growing regions in the insulin pens, syringes, pumps and injectors market will be Eastern Europe and the Middle East, where growth will be at CAGRs of 12.2% and 11.4% respectively from 2019-2023.
The insulin pens, syringes, pumps and injectors market is fairly fragmented, with a large number of small players. The top ten competitors in the market made up to 46.9% of the total market in 2019. Major players in the market include Eli Lilly and Company, Medtronic plc, Becton, Dickinson and Company, Novo Nordisk A/S, and Insulet Corporation.
The top growth potential in the insulin pens, syringes, pumps and injectors market by type of device will arise in pens market, which will gain $3,185.8 million of global annual sales by 2023. The top growth potential in the insulin pens, syringes, pumps and injectors market by end user will arise in homecare market, which will gain $3,779.0 million of global annual sales by 2023. The insulin pens, syringes, pumps and injectors market size will gain the most in the USA at $2,360.4 million. Market-trend-based strategies for the insulin pens, syringes, pumps and injectors market include focusing on developing combination devices of pump and monitoring system, manufacturing smart insulin pens, investing in developing patch pumps, investing in developing new types of insulin delivery devices for GRIs, and developing needle free insulin injectors. Player-adopted strategies in the insulin pens, syringes, pumps and injectors market include Business strategies adopted by major companies in the insulin pens, syringes, pumps and injectors market include expanding business through collaborations and partnerships, enhancing product portfolio through acquisition of medical technology companies, and expansion through sustainable investments. The unprecedented outbreak of corona virus increased the demand for insulin products globally. Companies should closely monitor the situation and increase the production to support the sudden surge in demand owing to the corona pandemic.
The global insulin pens, syringes, pumps and injectors market reached a value of nearly $16,148.7 million in 2019, having grown at a compound annual growth rate (CAGR) of 7.42% since 2015, and is expected to grow at a CAGR of 8.71% to nearly $22,553.3 million by 2023. Also, the market is expected to grow to $26,335.1 million in 2025 at a CAGR of 8.06% and to $ 38,137.9 million in 2030 at a CAGR of 7.69%.
Growth in the historic period resulted from increase in diabetes prevalence, increase in R&D investments and research collaborations, and increase in disposable income. Factors that negatively affected growth in the historic period were lack of awareness, and preference for oral treatment.
Going forward, rise in diabetic population, rapid technological advances, and favorable government initiatives are expected to drive the market. Factors that could hinder the growth of the insulin pens, syringes, pumps and injectors market in the future include government regulations, and availability of alternative treatments.
The insulin pens, syringes, pumps and injectors market is segmented by type of device into pens, injectors and pumps, and syringes. The pens market was the largest segment of the insulin pens, syringes, pumps and injectors market, accounting for $7,698.1 million or 47.7% of the total market in 2019. It is also expected to be the fastest growing segment going forward at a CAGR of 9.0% during 2019-2023.
The insulin pens, syringes, pumps and injectors market is also segmented by type of end user into homecare, hospitals, and others. The homecare was the largest segment of the insulin pens, syringes, pumps and injectors market by end user, accounting for $8,951.9 million or 55.4% of the total market in 2019. It is also expected to be the fastest-growing segment going forward at a CAGR of 9.2% during 2019-2023.
The pens market is further segmented by type of pens into disposable pens, and reusable pens. The disposable pens was the largest segment of the pens market by type of pen, accounting for $4,739.1 million or 61.6% of the total market in 2019. It is also expected to be the fastest-growing segment going forward at a CAGR of 9.4% during 2019-2023.
The injectors and pumps market is further segmented by type of injectors and pumps into pumps, and injectors. The pumps was the largest segment of the injectors and pumps market by type, accounting for $3,616.8 million or 53.5% of the total market in 2019. It is also expected to be the fastest-growing segment going forward at a CAGR of 9.6% during 2019-2023.
The pumps market is further segmented by type of pumps into tubed, and tubeless. The tubed pumps was the largest segment of the pumps market by type of pump, accounting for $ 2,750.0 million or 76.0% of the total market in 2019. The tubeless pumps segment is expected to be the fastest-growing segment going forward at a CAGR of 18.5% during 2019-2023.
North America was the largest region in the insulin pens, syringes, pumps and injectors market, accounting for 47.3% of the global market in 2019. It was followed by Asia Pacific and Western Europe, and the other regions. Going forward, the fastest growing regions in the insulin pens, syringes, pumps and injectors market will be Eastern Europe and the Middle East, where growth will be at CAGRs of 12.2% and 11.4% respectively from 2019-2023.
The insulin pens, syringes, pumps and injectors market is fairly fragmented, with a large number of small players. The top ten competitors in the market made up to 46.9% of the total market in 2019. Major players in the market include Eli Lilly and Company, Medtronic plc, Becton, Dickinson and Company, Novo Nordisk A/S, and Insulet Corporation.
The top growth potential in the insulin pens, syringes, pumps and injectors market by type of device will arise in pens market, which will gain $3,185.8 million of global annual sales by 2023. The top growth potential in the insulin pens, syringes, pumps and injectors market by end user will arise in homecare market, which will gain $3,779.0 million of global annual sales by 2023. The insulin pens, syringes, pumps and injectors market size will gain the most in the USA at $2,360.4 million. Market-trend-based strategies for the insulin pens, syringes, pumps and injectors market include focusing on developing combination devices of pump and monitoring system, manufacturing smart insulin pens, investing in developing patch pumps, investing in developing new types of insulin delivery devices for GRIs, and developing needle free insulin injectors. Player-adopted strategies in the insulin pens, syringes, pumps and injectors market include Business strategies adopted by major companies in the insulin pens, syringes, pumps and injectors market include expanding business through collaborations and partnerships, enhancing product portfolio through acquisition of medical technology companies, and expansion through sustainable investments. The unprecedented outbreak of corona virus increased the demand for insulin products globally. Companies should closely monitor the situation and increase the production to support the sudden surge in demand owing to the corona pandemic.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Eli Lilly and Company
- Abbott
- Arkray
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Biocon Ltd.
- Dexcom
- F. Hoffmann-La Roche AG
- Hindustan Syringes & Medical Devices
- Insujet
- Insulet Corporation
- Medtronic plc
- NIPRO
Note: Product cover images may vary from those shown
LOADING...
![Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] - Global Forecast to 2028 - Product Image](http://www.researchandmarkets.com/product_images/12194/12194704_60px_jpg/diabetes_care_devices_market.jpg)
